Previous studies showed that Sesn2 prevents NAFLD and protects against hepatic fibrosis induced by various drugs (Yang et al., 2019; Han et al., 2020). This evidence concerns the gene SESN2 and metabolic dysfunction-associated steatotic liver disease.